doi,title,pdf_path,record_idx,study_type,cell_type,barrier_category,barrier_name,dosage_form,api_conc_raw,diffusion_area_cm2,endpoint_type,endpoint_value,endpoint_unit,endpoint_time_value,endpoint_time_unit,needs_supp,confidence,notes
10.1002/etc.4302,Effects of skin region and relative lipophilicity on percutaneous absorption in the toad Rhinella marina.,GenAI\papers\pdf\10.1002_etc.4302__89ec992d2c.pdf,1,IVPT,Franz,skin,ventral pelvic,saturated solution,2.75 g/L HPβCD,,Q_final,,ug/cm2,1440.0,min,no,0.9,"Endpoint value appears only graphically; hence, set to null."
10.1007/s11095-020-02887-9,Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems,GenAI\papers\pdf\10.1007_s11095-020-02887-9__71e83a4015.pdf,1,IVPT,Franz,skin,neonatal porcine skin,HFMN arrays,40% w/w,,Q_final,,mg/cm²,24.0,h,no,0.95,"Endpoint appears in the figure, numeric value not provided."
10.1007/s11095-024-03747-6,Fluorinated PAMAM-Arginine Carrier Prodrugs for pH-Sensitive Sustained Ibuprofen Delivery,GenAI\papers\pdf\10.1007_s11095-024-03747-6__42a2bcfb6b.pdf,1,IVPT,Franz,skin,HUVEC,Fluorinated PAMAM-Arginine conjugate 1,10 mg/mL,,Q_final,,%,72.0,h,no,0.9,"Endpoint appears only in figures without numeric values, thus marked as null."
10.1007/s11095-024-03747-6,Fluorinated PAMAM-Arginine Carrier Prodrugs for pH-Sensitive Sustained Ibuprofen Delivery,GenAI\papers\pdf\10.1007_s11095-024-03747-6__42a2bcfb6b.pdf,2,IVPT,Franz,skin,HUVEC,Fluorinated PAMAM-Arginine conjugate 2,10 mg/mL,,Q_final,,%,72.0,h,no,0.9,"Endpoint appears only in figures without numeric values, thus marked as null."
10.1007/s11356-025-36536-8,Emerging contaminants: assessing the release of pharmaceuticals via managed aquifer recharge,GenAI\papers\pdf\10.1007_s11356-025-36536-8__a200c247b9.pdf,1,IVRT,Franz,both,N/A,100 µg/L solution,100 µg/L,,Q_final,,mg/L,,N/A,no,0.8,No specific numeric diffusion area provided; endpoint value is null as values are inferred from graphs only.
10.1007/s11356-025-36536-8,Emerging contaminants: assessing the release of pharmaceuticals via managed aquifer recharge,GenAI\papers\pdf\10.1007_s11356-025-36536-8__a200c247b9.pdf,2,IVPT,diffusion_cell_unspecified,skin,N/A,100 µg/L solution,100 µg/L,,Q_final,,mg/L,,N/A,no,0.75,"Similar to previous record, endpoint is null due to lack of numeric reporting."
10.1007/s12247-017-9305-x,Transdermal Delivery of Ibuprofen Utilizing a Novel Solvent-Free Pressure-sensitive Adhesive (PSA): TEPI® Technology,GenAI\papers\pdf\10.1007_s12247-017-9305-x__5da0ee39f0.pdf,1,IVPT,Franz,skin,Human Skin,Transdermal Patch,10 wt%,1.0,Q_final,85.73,µg cm−2,24.0,h,no,0.95,Endpoint value and formulation are provided in the main text.
10.1016/j.ijpx.2023.100205,Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions.,GenAI\papers\pdf\10.1016_j.ijpx.2023.100205__36b2f722d0.pdf,1,IVPT,Franz,skin,human epidermis,SLN,1% w/w,,Q_final,,mg/cm2,24.0,h,no,0.95,Endpoint appears only in figures and lacks explicit numeric values.
10.1016/j.ijpx.2023.100205,Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions.,GenAI\papers\pdf\10.1016_j.ijpx.2023.100205__36b2f722d0.pdf,2,IVPT,Franz,skin,human epidermis,SLN,1% w/w,,Q_final,,mg/cm2,12.0,h,no,0.95,Endpoint appears only in figures and lacks explicit numeric values.
10.1016/j.ijpx.2023.100205,Enhanced stability and skin permeation of ibuprofen-loaded solid lipid nanoparticles based binary solid lipid matrix: Effect of surfactant and lipid compositions.,GenAI\papers\pdf\10.1016_j.ijpx.2023.100205__36b2f722d0.pdf,3,IVRT,Franz,synthetic_membrane,---,SLN,1% w/w,,flux,6.5,mg/cm2/h,1.0,h,no,0.95,This endpoint provided numeric values explicitly.
10.1016/j.jsps.2017.03.004,Vapour-phase method in the synthesis of polymer-ibuprofen sodium-silica gel composites,GenAI\papers\pdf\10.1016_j.jsps.2017.03.004__e3d1f0291a.pdf,1,IVRT,Franz,both,poly(TRIM) and poly(HEMA-co-TRIM) composites,Polymer-ibuprofen sodium-silica gel composite,39 mg/g,,Q_final,,mL,15.0,min,no,0.8,The endpoint value set to null as it could not be derived from figures.
10.1021/acs.molpharmaceut.0c00515,Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.,GenAI\papers\pdf\10.1021_acs.molpharmaceut.0c00515__ab30082c93.pdf,1,IVRT,diffusion_cell_unspecified,skin,poly(caprolactone) coating,implant,68.1 ± 3.0 mg,,Q_final,,mg/day,,,no,0.9,
10.1021/acs.molpharmaceut.0c00515,Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.,GenAI\papers\pdf\10.1021_acs.molpharmaceut.0c00515__ab30082c93.pdf,2,IVRT,diffusion_cell_unspecified,skin,poly(caprolactone) coating,implant,68.1 ± 3.0 mg,,Q_final,,mg/day,,,no,0.9,
10.1021/acs.molpharmaceut.0c00515,Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs.,GenAI\papers\pdf\10.1021_acs.molpharmaceut.0c00515__ab30082c93.pdf,3,IVRT,diffusion_cell_unspecified,skin,poly(caprolactone) coating,implant,68.1 ± 3.0 mg,,Q_final,,mg/day,,,no,0.9,
10.1021/acs.molpharmaceut.1c00988,Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches,GenAI\papers\pdf\10.1021_acs.molpharmaceut.1c00988__320ca28dae.pdf,1,IVPT,Franz,skin,full-thickness neonatal porcine skin,microneedle array patches,30% drug,0.36,Q_final,75.0,%,24.0,hours,no,0.9,Table provides marked data for drug concentration and delivery outcomes.
10.1021/acsomega.7b01800,Drug-Loaded Supramolecular Gels Prepared in a Microfluidic Platform: Distinctive Rheology and Delivery through Controlled Far-from-Equilibrium Mixing,GenAI\papers\pdf\10.1021_acsomega.7b01800__9d283ba697.pdf,1,IVPT,Franz,skin,Franz cell,gel,1:1 molar ratio,6.0,Q_final,7.0,mg,24.0,h,no,0.9,Endpoint is numeric based on provided tables.
10.1021/acsomega.8b00185,Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration.,GenAI\papers\pdf\10.1021_acsomega.8b00185__4bbfba07e6.pdf,1,IVRT,Franz,skin,MIL-100,Formulated,30.6 ± 0.9 (1.0 mol·mol−1),,Q_final,84.0,%,1.0,day,no,0.95,
10.1021/acsomega.8b00185,Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration.,GenAI\papers\pdf\10.1021_acsomega.8b00185__4bbfba07e6.pdf,2,IVPT,Franz,skin,UiO-66,Formulated,35.5 ± 3.2 (3.7 mol·mol−1),,Q_final,46.0,%,1.0,day,no,0.95,
10.1038/s41467-017-00763-6,Printing of small molecular medicines from the vapor phase.,GenAI\papers\pdf\10.1038_s41467-017-00763-6__d818b9d77d.pdf,1,IVPT,Franz,skin,Tegaderm,Film,70 μg,0.7854,Q_final,0.333,mg/mL,60.0,min,no,0.9,This record represents results from ibuprofen film deposited on Tegaderm using OVJP.
10.1038/s41598-022-05912-6,Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery.,GenAI\papers\pdf\10.1038_s41598-022-05912-6__a14138d102.pdf,1,IVPT,Franz,skin,porcine skin,microneedle patches,not stated.,120.0,Q_final,1.0,mg,120.0,min,no,0.95,"Data extracted directly from study, numerical values provided."
10.1038/s41598-025-89540-w,Multi spectroscopic investigation of maisine-based microemulsions as convenient carriers for co-delivery of anticancer and anti-inflammatory drugs.,GenAI\papers\pdf\10.1038_s41598-025-89540-w__8b4b299fb0.pdf,1,IVPT,Franz,both,both,microemulsion,1% (6% IBU),,Q_final,,mg/mL,96.0,h,no,0.8,"Endpoint values only found in figures without numeric representation; thus, they are set to null."
10.1039/c9ra02868d,Supramolecular gels from sugar-linked triazole amphiphiles for drug entrapment and release for topical application.,GenAI\papers\pdf\10.1039_c9ra02868d__d723b2a34a.pdf,1,IVPT,Franz,skin,human skin,gel,1.5% w/v,,Q_final,,µg/cm²,36.0,h,no,0.9,Endpoint value could not be extracted from numeric data; described as null as figures only contain qualitative values.
10.1039/d0ra00100g,Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters,GenAI\papers\pdf\10.1039_d0ra00100g__a0517498c9.pdf,1,IVPT,Franz,skin,porcine skin,in solution,0.01 g cm-3,1.0,Q_final,,mg cm-2,24.0,h,no,0.9,The endpoint was not provided as a numeric value but mentioned in the context.
10.1039/d0ra00100g,Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters,GenAI\papers\pdf\10.1039_d0ra00100g__a0517498c9.pdf,2,IVPT,Franz,skin,porcine skin,in solution,0.01 g cm-3,1.0,Q_final,,mg cm-2,24.0,h,no,0.9,The endpoint was not provided as a numeric value but mentioned in the context.
10.1039/d0ra00100g,Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters,GenAI\papers\pdf\10.1039_d0ra00100g__a0517498c9.pdf,3,IVPT,Franz,skin,porcine skin,in solution,0.01 g cm-3,1.0,Q_final,,mg cm-2,24.0,h,no,0.9,The endpoint was not provided as a numeric value but mentioned in the context.
10.1039/d0ra00100g,Enhancement of ibuprofen solubility and skin permeation by conjugation with l-valine alkyl esters,GenAI\papers\pdf\10.1039_d0ra00100g__a0517498c9.pdf,4,IVPT,Franz,skin,porcine skin,in solution,0.01 g cm-3,1.0,Q_final,,mg cm-2,24.0,h,no,0.9,The endpoint was not provided as a numeric value but mentioned in the context.
10.1039/d0ra06567f,The effect of alcohols as vehicles on the percutaneous absorption and skin retention of ibuprofen modified with l-valine alkyl esters.,GenAI\papers\pdf\10.1039_d0ra06567f__15dc420ec6.pdf,1,IVPT,Franz,skin,porcine skin,ibuprofen solution in alcohol,1% (m/v) solution,,Q_final,411.76,mg,24.0,h,no,0.9,Isopropanol was confirmed to enhance ibuprofen permeation.
10.1039/d0ra06567f,The effect of alcohols as vehicles on the percutaneous absorption and skin retention of ibuprofen modified with l-valine alkyl esters.,GenAI\papers\pdf\10.1039_d0ra06567f__15dc420ec6.pdf,2,IVPT,Franz,skin,porcine skin,ibuprofen solution in alcohol,1% (m/v) solution,,Q_final,410.76,mg,24.0,h,no,0.9,Ethanol was noted as a significant solvent for permeation.
10.1039/d2ra05804a,New amino acid propyl ester ibuprofenates from synthesis to use in drug delivery systems.,GenAI\papers\pdf\10.1039_d2ra05804a__cf2f535409.pdf,1,IVPT,Franz,skin,pig skin,transdermal patch,4.775 g IBU per dm³,,Q_final,335.13,mg cm−2,24.0,h,no,0.9,Main endpoint value extracted from numerical data in Table 4.
10.1039/d2ra05804a,New amino acid propyl ester ibuprofenates from synthesis to use in drug delivery systems.,GenAI\papers\pdf\10.1039_d2ra05804a__cf2f535409.pdf,2,IVPT,Franz,skin,pig skin,transdermal patch,4.596 g IBU per dm³,,Q_final,454.86,mg cm−2,24.0,h,no,0.9,Main endpoint value extracted from numerical data in Table 4.
10.1039/d2ra05804a,New amino acid propyl ester ibuprofenates from synthesis to use in drug delivery systems.,GenAI\papers\pdf\10.1039_d2ra05804a__cf2f535409.pdf,3,IVPT,Franz,skin,pig skin,transdermal patch,4.188 g IBU per dm³,,Q_final,284.27,mg cm−2,24.0,h,no,0.9,Main endpoint value extracted from numerical data in Table 4.
10.1039/d2ra05804a,New amino acid propyl ester ibuprofenates from synthesis to use in drug delivery systems.,GenAI\papers\pdf\10.1039_d2ra05804a__cf2f535409.pdf,4,IVPT,Franz,skin,pig skin,transdermal patch,4.577 g IBU per dm³,,Q_final,319.22,mg cm−2,24.0,h,no,0.9,Main endpoint value extracted from numerical data in Table 4.
10.1039/d3na00102d,Ibuprofen-loaded electrospun poly(ethylene-co-vinyl alcohol) nanofibers for wound dressing applications.,GenAI\papers\pdf\10.1039_d3na00102d__3fe1ba65d9.pdf,1,IVRT,Franz,skin,EVOH membranes,EVOH-loaded with ibuprofen,10 (w/w)%,,Q_final,,mg/cm²,120.0,h,no,0.9,"Endpoint appears only in figures without numeric values, thus set to null."
10.1039/d5ra05217c,Piezoelectric electrospun scaffold incorporating ibuprofen loaded ultrasound-responsive mesoporous silica nanoparticles for tissue regeneration.,GenAI\papers\pdf\10.1039_d5ra05217c__c723345e54.pdf,1,IVPT,Franz,both,3D fibrous scaffold,nanoparticle suspension,1 mg mL−1,,Q_final,,mg/mL,7.0,days,no,0.8,"Endpoint value reported in figures without numeric values, thus set to null."
10.1080/10837450.2018.1509347,An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin.,GenAI\papers\pdf\10.1080_10837450.2018.1509347__a7e143a067.pdf,1,IVPT,Franz,skin,full-thickness human skin,"CPO, TRF",129.0 ± 1.2 mg/mL (CPO),,Q_final,30.6,mg/cm2 h,72.0,h,no,1.0,
10.1098/rsfs.2019.0132,In vitro and computational modelling of drug delivery across the outer blood-retinal barrier.,GenAI\papers\pdf\10.1098_rsfs.2019.0132__2fa2660da2.pdf,1,IVPT,Franz,both,outer blood-retinal barrier,silicone oil,1 mg/ml,,Q_final,,mg/ml,,h,no,0.9,The specific numeric values for endpoints appeared only in figures without accompanying data.
10.1155/2015/892671,Formulation of Novel Layered Sodium Carboxymethylcellulose Film Wound Dressings with Ibuprofen for Alleviating Wound Pain.,GenAI\papers\pdf\10.1155_2015_892671__9b42388c10.pdf,1,IVPT,Franz,skin,N/A,film,0.5 mg/cm2,4.73,Q_final,,mg/cm2,8.0,h,no,0.9,Endpoint value was indicated in figures but not numerically defined.
10.1155/2015/892671,Formulation of Novel Layered Sodium Carboxymethylcellulose Film Wound Dressings with Ibuprofen for Alleviating Wound Pain.,GenAI\papers\pdf\10.1155_2015_892671__9b42388c10.pdf,2,IVPT,Franz,skin,N/A,film,1.0 mg/cm2,4.73,Q_final,,mg/cm2,8.0,h,no,0.9,Endpoint value was indicated in figures but not numerically defined.
10.1186/2050-6511-13-5,Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points.,GenAI\papers\pdf\10.1186_2050-6511-13-5__eabb128fb8.pdf,1,IVPT,Franz,skin,bovine split skin,80% saturated solution in PBS,23.4 mg/ml,1.77,Q_final,431.52,μg/cm²/h,6.0,h,no,0.9,Endpoint value derived from Table 1.
10.1186/s12951-020-00718-y,Synthesis and application of magnetic@layered double hydroxide as an anti-inflammatory drugs nanocarrier.,GenAI\papers\pdf\10.1186_s12951-020-00718-y__c400793e91.pdf,1,IVPT,Franz,skin,n/a,Fe3O4@LDH-ibuprofen,not explicitly stated,8.0,Q_final,96.0,%,24.0,h,no,0.9,Effective release observed at specified times and areas.
10.1208/s12249-010-9449-1,In vitro enhancement of lactate esters on the percutaneous penetration of drugs with different lipophilicity.,GenAI\papers\pdf\10.1208_s12249-010-9449-1__20e37a8b8e.pdf,1,IVPT,Franz,skin,hairless rat skin,Topical,Saturated solution in propylene glycol,1.65,Q_final,375.71,μg/cm2/h,24.0,h,no,0.9,The endpoint was measured after a 24-hour duration.
10.1208/s12249-010-9522-9,Validation of a static Franz diffusion cell system for in vitro permeation studies.,GenAI\papers\pdf\10.1208_s12249-010-9522-9__9004f70379.pdf,1,IVPT,Franz,synthetic_membrane,cellulose membrane,Phorpain gel,5%,59.6,Q_final,36.4,μg cm−2h−1,,h,no,0.9,Endpoint values taken from flux analyses.
10.1208/s12249-013-9995-4,Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study.,GenAI\papers\pdf\10.1208_s12249-013-9995-4__48cbfe0b17.pdf,1,IVPT,Franz,skin,porcine skin,Nanosuspension gel,5% w/v,0.64,Q_final,1142.4,μg,72.0,h,no,0.95,
10.1208/s12249-015-0474-y,Regulating the Skin Permeation Rate of Escitalopram by Ion-pair Formation with Organic Acids.,GenAI\papers\pdf\10.1208_s12249-015-0474-y__b08f9feea7.pdf,1,IVPT,diffusion_cell_unspecified,skin,rabbit abdominal skin,transdermal patch,IB (concentration not specified),0.95,Q_final,224.48,μg/(cm2·h),8.0,h,no,0.95,The endpoint appears in a table with specific numeric values.
10.1371/journal.pone.0156931,Use of a Tissue Engineered Human Skin Model to Investigate the Effects of Wounding and of an Anti-Inflammatory on Melanoma Cell Invasion,GenAI\papers\pdf\10.1371_journal.pone.0156931__84dcffdf1d.pdf,1,IVPT,Franz,skin,de-epidermised acellular dermis (DED),hydrogel,300 U/ml,,Q_final,,ng/mL,19.0,days,no,0.85,Data from various figures indicate changes in invasion post ibuprofen treatment.
10.14440/jbm.2020.319,An ex vivo skin model to probe modulation of local cutaneous arachidonic acid inflammation pathway.,GenAI\papers\pdf\10.14440_jbm.2020.319__1be6b1975c.pdf,1,IVPT,Franz,skin,Porcine Skin,Topical Cream,10%,0.88,Q_final,5.2,ng/cm2,24.0,h,no,0.95,Data obtained directly from tables.
10.2147/ijn.s34700,Modification of palm kernel oil esters nanoemulsions with hydrocolloid gum for enhanced topical delivery of ibuprofen,GenAI\papers\pdf\10.2147_ijn.s34700__130ce08dfa.pdf,1,IVRT,Franz,skin,rat skin,nanoemulsion,2%,0.64,Q_final,49.32,µg/cm²,8.0,h,no,0.95,Endpoint values and evidence were directly stated in the text and tables.
10.22037/ijpr.2020.112887.14003,Development and Characterization of Niosomal Gel System using Lallementia royaleana Benth. mucilage for the treatment of Rheumatoid Arthritis.,GenAI\papers\pdf\10.22037_ijpr.2020.112887.14003__d40fecc1d7.pdf,1,IVPT,Franz,both,skin,Niosomal gel,720 µg/100 g,,Q_final,1.999,mg cm-2,8.0,h,no,0.9,All formulations are based on the niosomal gel containing ibuprofen.
10.22037/ijpr.2020.112887.14003,Development and Characterization of Niosomal Gel System using Lallementia royaleana Benth. mucilage for the treatment of Rheumatoid Arthritis.,GenAI\papers\pdf\10.22037_ijpr.2020.112887.14003__d40fecc1d7.pdf,2,IVRT,diffusion_cell_unspecified,skin,rat skin,Ibuprofen loaded niosomal gel,720 µg/100 g,,Jss,10.66,mg cm-2 h-1,1.0,h,no,0.85,Different formulations of the ibuprofen loaded niosomal gel were tested.
10.3390/antibiotics10070805,In Vitro Microbiological and Drug Release of Silver/Ibuprofen Loaded Wound Dressing Designed for the Treatment of Chronically Infected Painful Wounds.,GenAI\papers\pdf\10.3390_antibiotics10070805__b6bca2ab5d.pdf,1,IVPT,Franz,both,PET fabric,wound dressing,93 ± 4 µg/cm2,25.0,Q_final,12.0,mg/L,6.0,h,no,0.95,The endpoint values were clearly defined within the tables and text.
10.3390/gels10110704,Decellularized Macroalgae as Complex Hydrophilic Structures for Skin Tissue Engineering and Drug Delivery,GenAI\papers\pdf\10.3390_gels10110704__b52d02c892.pdf,1,IVPT,Franz,skin,Human skin,Hydrogel,71 ± 2 µg/mg (green algae SDS),,Q_final,,%,6.0,h,no,0.95,"The endpoint value is specifically not provided in numeric format within the text, only implied through experimental context."
10.3390/gels10110704,Decellularized Macroalgae as Complex Hydrophilic Structures for Skin Tissue Engineering and Drug Delivery,GenAI\papers\pdf\10.3390_gels10110704__b52d02c892.pdf,2,IVRT,Franz,skin,Human skin,Hydrogel,66 ± 5 µg/mg (green algae Triton),,Q_final,,%,6.0,h,no,0.95,"The endpoint value is specifically not provided in numeric format within the text, only implied through experimental context."
10.3390/gels10110704,Decellularized Macroalgae as Complex Hydrophilic Structures for Skin Tissue Engineering and Drug Delivery,GenAI\papers\pdf\10.3390_gels10110704__b52d02c892.pdf,3,IVRT,Franz,skin,Human skin,Hydrogel,62 ± 4 µg/mg (red algae SDS),,Q_final,,%,6.0,h,no,0.95,"The endpoint value is specifically not provided in numeric format within the text, only implied through experimental context."
10.3390/gels10110704,Decellularized Macroalgae as Complex Hydrophilic Structures for Skin Tissue Engineering and Drug Delivery,GenAI\papers\pdf\10.3390_gels10110704__b52d02c892.pdf,4,IVRT,Franz,skin,Human skin,Hydrogel,56 ± 3 µg/mg (red algae Triton),,Q_final,,%,6.0,h,no,0.95,"The endpoint value is specifically not provided in numeric format within the text, only implied through experimental context."
10.3390/gels11010041,Permeation Enhancer in Microemulsions and Microemulsion-Based Gels: A Comparison of Diethylene Glycol Monoethyl Ether and Oleyl Alcohol,GenAI\papers\pdf\10.3390_gels11010041__cb148324e0.pdf,1,IVPT,Franz,skin,Strat-M® membrane,microemulsion-gel,5% w/w,,Q_final,127.4,µg/cm2/h,24.0,h,no,0.95,Formulation F2 showed significant higher permeation.
10.3390/gels11010041,Permeation Enhancer in Microemulsions and Microemulsion-Based Gels: A Comparison of Diethylene Glycol Monoethyl Ether and Oleyl Alcohol,GenAI\papers\pdf\10.3390_gels11010041__cb148324e0.pdf,2,IVPT,Franz,skin,Strat-M® membrane,microemulsion-gel,5% w/w,,Q_final,124.5,µg/cm2/h,24.0,h,no,0.95,"Formulation F1, lower permeation than F2."
10.3390/ijms242115632,Enhancing Transdermal Delivery: Investigating the Impact of Permeation Promoters on Ibuprofen Release and Penetration from Medical Patches-In Vitro Research,GenAI\papers\pdf\10.3390_ijms242115632__cc885c7871.pdf,1,IVPT,Franz,skin,Human Skin,Transdermal Patch,5%,9.6,Q_final,2.8,mg/cm2,24.0,h,no,0.95,Results indicate significantly improved permeation with the use of enhancers.
10.3390/ijms242115632,Enhancing Transdermal Delivery: Investigating the Impact of Permeation Promoters on Ibuprofen Release and Penetration from Medical Patches-In Vitro Research,GenAI\papers\pdf\10.3390_ijms242115632__cc885c7871.pdf,2,IVRT,Franz,skin,Human Skin,Transdermal Patch,5%,10.0,flux,5.0,mg/cm2/h,1.0,h,no,0.9,Enhanced flux observed with menthol.
10.3390/ijms242115632,Enhancing Transdermal Delivery: Investigating the Impact of Permeation Promoters on Ibuprofen Release and Penetration from Medical Patches-In Vitro Research,GenAI\papers\pdf\10.3390_ijms242115632__cc885c7871.pdf,3,IVPT,Franz,skin,Human Skin,Transdermal Patch,5%,11.2,Q_final,3.2,mg/cm2,36.0,h,no,0.85,Higher penetration noted with glycerin.
10.3390/membranes12080762,In Situ Generation of Fouling Resistant Ag/Pd Modified PES Membranes for Treatment of Pharmaceutical Wastewater.,GenAI\papers\pdf\10.3390_membranes12080762__fa6875b6e1.pdf,1,IVRT,Franz,skin,PES membrane,membrane filtration,5 mg·L−1,,Q_final,,L·m−2h−1bar−1,,,no,0.8,Endpoint value not directly provided as numeric; may appear in figures but was not extractable.
10.3390/nano10112165,Embedding Ordered Mesoporous Carbons into Thermosensitive Hydrogels: A Cutting-Edge Strategy to Vehiculate a Cargo and Control Its Release Profile,GenAI\papers\pdf\10.3390_nano10112165__6748e42f34.pdf,1,IVPT,Franz,skin,Franz Cell,Hydrogel,10 mg/mL,,Q_final,,mg,,,no,0.9,
10.3390/nano10112165,Embedding Ordered Mesoporous Carbons into Thermosensitive Hydrogels: A Cutting-Edge Strategy to Vehiculate a Cargo and Control Its Release Profile,GenAI\papers\pdf\10.3390_nano10112165__6748e42f34.pdf,2,IVRT,Franz,synthetic_membrane,Franz Cell,Hydrogel,10 mg/mL,,Q_final,,mg,,,no,0.9,
10.3390/pharmaceutics12020151,Evaluation of Formulation Parameters on Permeation of Ibuprofen from Topical Formulations Using Strat-M® Membrane,GenAI\papers\pdf\10.3390_pharmaceutics12020151__701029bf55.pdf,1,IVPT,Franz,skin,Strat-M® membrane,Cream,3% w/w,0.785,Q_final,163.2,µg/cm2,24.0,h,no,0.9,
10.3390/pharmaceutics12020151,Evaluation of Formulation Parameters on Permeation of Ibuprofen from Topical Formulations Using Strat-M® Membrane,GenAI\papers\pdf\10.3390_pharmaceutics12020151__701029bf55.pdf,2,IVPT,Franz,skin,Strat-M® membrane,Cream,5% w/w,0.785,Q_final,320.8,µg/cm2,24.0,h,no,0.9,
10.3390/pharmaceutics12020151,Evaluation of Formulation Parameters on Permeation of Ibuprofen from Topical Formulations Using Strat-M® Membrane,GenAI\papers\pdf\10.3390_pharmaceutics12020151__701029bf55.pdf,3,IVPT,Franz,skin,Strat-M® membrane,Emulgel,3% w/w,0.785,Q_final,178.5,µg/cm2,24.0,h,no,0.9,
10.3390/pharmaceutics12020151,Evaluation of Formulation Parameters on Permeation of Ibuprofen from Topical Formulations Using Strat-M® Membrane,GenAI\papers\pdf\10.3390_pharmaceutics12020151__701029bf55.pdf,4,IVPT,Franz,skin,Strat-M® membrane,Gel,3% w/w,0.785,Q_final,739.6,µg/cm2,24.0,h,no,0.9,
10.3390/pharmaceutics13111952,Polyelectrolyte-Coated Mesoporous Bioactive Glasses via Layer-by-Layer Deposition for Sustained Co-Delivery of Therapeutic Ions and Drugs.,GenAI\papers\pdf\10.3390_pharmaceutics13111952__45146cae8a.pdf,1,IVPT,Franz,synthetic_membrane,Cu-substituted MBGs,ibuprofen,30 mg/mL,,Q_final,,mg/mL,24.0,h,no,0.9,"Endpoint appears absent in numeric form in figures, remains unspecified."
10.3390/pharmaceutics2020209,A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.,GenAI\papers\pdf\10.3390_pharmaceutics2020209__1a2e9fadde.pdf,1,IVPT,Franz,synthetic_membrane,Cellulose nitrate,saturated solution,2.0 % (w/v),59.6,Q_final,97.89,mg/cm2,6.0,h,no,0.9,
10.3390/pharmaceutics2020209,A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.,GenAI\papers\pdf\10.3390_pharmaceutics2020209__1a2e9fadde.pdf,2,IVPT,Franz,synthetic_membrane,Nuclepore,saturated solution,2.0 % (w/v),59.6,Q_final,97.75,mg/cm2,6.0,h,no,0.9,
10.3390/pharmaceutics2020209,A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.,GenAI\papers\pdf\10.3390_pharmaceutics2020209__1a2e9fadde.pdf,3,IVPT,Franz,synthetic_membrane,Celgard,saturated solution,2.0 % (w/v),59.6,Q_final,67.28,mg/cm2,6.0,h,no,0.9,
10.3390/pharmaceutics2020209,A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.,GenAI\papers\pdf\10.3390_pharmaceutics2020209__1a2e9fadde.pdf,4,IVPT,Franz,synthetic_membrane,Cyclopore,saturated solution,2.0 % (w/v),59.6,Q_final,86.32,mg/cm2,6.0,h,no,0.9,
10.3390/pharmaceutics2020209,A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells.,GenAI\papers\pdf\10.3390_pharmaceutics2020209__1a2e9fadde.pdf,5,IVPT,Franz,synthetic_membrane,Tuffryn,saturated solution,2.0 % (w/v),59.6,Q_final,77.23,mg/cm2,6.0,h,no,0.9,
10.3390/polym15040791,"Chitin-Glucan Complex Hydrogels: Physical-Chemical Characterization, Stability, In Vitro Drug Permeation, and Biological Assessment in Primary Cells.",GenAI\papers\pdf\10.3390_polym15040791__a37a825452.pdf,1,IVPT,Franz,skin,Strat-M,hydrogel,1.0 wt%,3.14,Q_final,4.26,µg/cm2/h,1.0,h,no,0.9,No multiple formulations stated; this record is singular.
10.3390/polym16142006,Cellulose Acetate and Polycaprolactone Fibre Coatings on Medical-Grade Metal Substrates for Controlled Drug Release,GenAI\papers\pdf\10.3390_polym16142006__02ac8ba9aa.pdf,1,IVPT,diffusion_cell_unspecified,skin,medical-grade stainless steel,membrane,0.5 g/L,,Q_final,,mg,190.0,h,no,0.85,"Endpoint value appears only in figures without numeric values, hence set to null."
